<DOC>
	<DOCNO>NCT01039558</DOCNO>
	<brief_summary>We estimate response lansoprazole ecabet sodium combination therapy compare lansoprazole placebo therapy patient need additional therapy standard proton pump inhibitor treatment 4week recurrent gastroesophageal reflux disease .</brief_summary>
	<brief_title>The Effect Lansoprazole Combination With Ecabet Sodium Gastroesophageal Reflux Disease</brief_title>
	<detailed_description />
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Lansoprazole</mesh_term>
	<mesh_term>Dexlansoprazole</mesh_term>
	<mesh_term>Ecabet</mesh_term>
	<criteria>age 1975 year patient typical gastroesophageal symptom erosive reflux esophagitis gastroduodenoscopy patient recurrent gastroesophageal symptom standard proton pump inhibitor treatment 4 week patient gastric ulcer duodenal ulcer patient gastric cancer esophageal cancer pregnant postpartum woman</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>gastroesophageal reflux disease</keyword>
	<keyword>lansoprazole</keyword>
	<keyword>ecabet sodium</keyword>
</DOC>